The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...

The revamped vaccine is an effort by regulators and vaccine makers to keep pace with the virus, which continues to evolve ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...

Each household can receive up to four free tests from the site COVIDtest.gov. Once ordered, the at-home tests are mailed to ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

The Florida Department of Health, run by Surgeon General Dr. Joseph Ladapo, just released guidance on COVID-19 vaccines based ...

Pfizer and BioNTech said their alliance aims to develop an "improved" vaccine for shingles ... after the COVID-19 shot and a candidate for influenza that is currently in clinical trials.

BioNTech vaccine for children may be available in Hong Kong by October “The chances of Covid-19 outbreaks are relatively small in the winter. Instead, influenza has a higher chance of outbreaks ...

The global lipid nanoparticles market is expected to grow from USD 271.8 million in 2024 to USD 350.5 million by 2029, with a ...

Some information you come across about COVID-19 may be out of date or false. Learn about COVID-19 myths so you can bust them when you see them.